[Infection prophylaxis in granulocytopenia by clinical gnotobiotics].
D000380:Agranulocytosis / Q000139:chemically induced* / Q000150:complications; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003428:Cross Infection / Q000517:prevention & control*; D005260:Female; D005856:Germ-Free Life; D006801:Humans; D016030:Kidney Transplantation; D007938:Leukemia / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D010357:Patient Isolators
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents
Infektprophylaxe bei Granulozytopenie durch klinische Gnotobiotik.